Correlation Between Pharmaceuticals Ultrasector and Ultramid-cap Profund

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Ultramid-cap Profund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Ultramid-cap Profund into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Ultramid Cap Profund Ultramid Cap, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Ultramid-cap Profund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Ultramid-cap Profund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Ultramid-cap Profund.

Diversification Opportunities for Pharmaceuticals Ultrasector and Ultramid-cap Profund

0.71

Correlation Coefficient

Pharmaceuticals Ultrasector  Ultramid-cap Profund

Poor diversification

The 3 months correlation between Pharmaceuticals and Ultramid-cap is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Ultramid Cap Profund Ultramid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultramid Cap Profund and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Ultramid-cap Profund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultramid Cap Profund has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Ultramid-cap Profund go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Ultramid-cap Profund

Assuming the 90 days horizon Pharmaceuticals Ultrasector is expected to generate 2.77 times less return on investment than Ultramid-cap Profund. But when comparing it to its historical volatility, Pharmaceuticals Ultrasector Profund is 1.23 times less risky than Ultramid-cap Profund. It trades about 0.08 of its potential returns per unit of risk. Ultramid Cap Profund Ultramid Cap is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  6,428  in Ultramid Cap Profund Ultramid Cap on September 3, 2024 and sell it today you would earn a total of  1,459  from holding Ultramid Cap Profund Ultramid Cap or generate 22.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Ultramid Cap Profund Ultramid

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Ultramid Cap Profund

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ultramid Cap Profund Ultramid Cap are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Ultramid-cap Profund showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmaceuticals Ultrasector and Ultramid-cap Profund

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Ultramid-cap Profund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Ultramid-cap Profund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultramid-cap Profund will offset losses from the drop in Ultramid-cap Profund's long position.

The idea behind Pharmaceuticals Ultrasector Profund and Ultramid Cap Profund Ultramid Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.